{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fpoll-hub.simplecast.com%2Fepisodes%2Fthe-future-of-cancer-EYa_f679","width":444,"version":"1.0","type":"rich","title":"The Future of Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/ace6a000-fede-4d53-b882-1f409d50a024/329f6c15-69ab-4b79-90dc-0e42366fba83/1920x1080_5.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/88912d03-6d9f-4f55-b858-eb549aa2b6e9\" height=\"200\" width=\"100%\" title=\"The Future of Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"On this week's Poll Hub: \n\nCancer remains one of the most widespread diseases in the United States. While treatments have improved and survival rates continue to rise, more Americans are being diagnosed, including younger populations, raising new questions about prevention and risk.\n\nAt the same time, cancer care is rapidly evolving. Breakthroughs in targeted therapies and immunotherapies are helping patients live longer, and, in many cases, shifting cancer into something that can be managed over time rather than immediately life-threatening.\n\nHowever, progress comes with tradeoffs. Cancer is not a single disease, and its impact goes far beyond treatment, shaping long-term physical, emotional, and financial realities for patients. Joined by Dr. Thomas Blom of Princeton Medical Group and Penn Medicine, we explore where we stand today and where cancer care is headed next.\n\nmaristpoll.com/podcast"}